ArticleCell reports. Medicine2021

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy.

Yan-Ruide Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.